Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trial

Drug and Alcohol Dependence

Volumn 113, Issue 2-3, 2011, Pages 192-199

  Berg, Karina M ^a   Litwin, Alain ^a   Li, Xuan ^a   Heo, Moonseong ^a   Arnsten, Julia H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Directly observed therapy; HIV; Medication adherence; Methadone; Randomized trial

Indexed keywords

AMPHETAMINE; ANTIRETROVIRUS AGENT; CANNABIS; COCAINE; DIAMORPHINE; METHADONE; OPIATE;

ADULT; ALCOHOLISM; ARTICLE; DIRECTLY OBSERVED THERAPY; DRUG ABUSE; DRUG EFFICACY; DRUG SELF ADMINISTRATION; FEMALE; HEALTH CARE AVAILABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OPIATE ADDICTION; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; TREATMENT DURATION; UNITED STATES; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DIRECTLY OBSERVED THERAPY; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; SUBSTANCE ABUSE TREATMENT CENTERS; VIRAL LOAD;

EID: 78651494300     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.07.025     Document Type: Article

References (39)

1. Altice F.L., Maru D.S., Bruce R.D., Springer S.A., Friedland G.H. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. Clin. Infect. Dis. 2007, 45:770-778.
2. Altice F.L., Mezger J.A., Hodges J., Bruce R.D., Marinovich A., Walton M., Springer S.A., Friedland G.H. Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication. Clin. Infect. Dis. 2004, 38(Suppl 5):S376-S387.
3. Arnsten J.H., Demas P.A., Grant R.W., Gourevitch M.N., Farzadegan H., Howard A.A., Schoenbaum E.E. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J. Gen. Intern. Med. 2002, 17:377-381.
4. Babudieri S., Aceti A., D'Offizi G.P., Carbonara S., Starnini G. Directly observed therapy to treat HIV infection in prisoners. JAMA 2000, 284:179-180.
5. Batki S.L., Gruber V.A., Bradley J.M., Bradley M., Delucchi K. A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. Drug Alcohol Depend. 2002, 66:283-293.
6. Behforouz H.L., Kalmus A., Scherz C.S., Kahn J.S., Kadakia M.B., Farmer P.E. Directly observed therapy for HIV antiretroviral therapy in an urban US setting. J. Acquir. Immune. Defic. Syndr. 2004, 36:642-645.
7. Berg K.M., Demas P.A., Howard A.A., Schoenbaum E.E., Gourevitch M.N., Arnsten J.H. Gender differences in factors associated with adherence to antiretroviral therapy. J. Gen. Intern. Med. 2004, 19:1111-1117.
8. Berg K.M., Mouriz J., Li X., Duggan E., Goldberg U., Arnsten J.H. Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics. Contemp. Clin. Trials. 2009, 30:481-489.
9. Chaulk C.P., Kazandjian V.A. Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel. JAMA 1998, 279:943-948.
10. Chesney M.A., Ickovics J.R., Chambers D.B., Gifford A.L., Neidig J., Zwickl B., Wu A.W. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000, 12:255-266.
11. Clarke S., Keenan E., Ryan M., Barry M., Mulcahy F. Directly observed antiretroviral therapy for injection drug users with HIV infection. AIDS Read. 2002, 12:305-306.
12. Conway B., Prasad J., Reynolds R., Farley J., Jones M., Jutha S., Smith N., Mead A., DeVlaming S. Directly observed therapy for the management of HIV-infected patients in a methadone program. Clin. Infect. Dis. 2004, 38(Suppl 5):S402-S408.
13. Cooperman N.A., Parsons J.T., Chabon B., Berg K.M., Arnsten J.H. The Development and Feasibility of an Intervention to Improve HAART Adherence Among HIV-Positive Patients Receiving Primary Care in Methadone Clinics. J. HIV/AIDS & Social. Serv. 2007, 6:101-120.
14. DesJarlais D.C., Paone D., Milliken J., Turner C.F., Miller H., Gribble J., Shi Q., Hagan H., Friedman S.R. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet 1999, 353:1657-1661.
15. Ford N., Nachega J.B., Engel M.E., Mills E.H. Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials. Lancet 2009, 374(9707):2064-2071.
16. Goggin K., Liston R.J., Mitty J.A. Modified directly observed therapy for antiretroviral therapy: a primer from the field. Public Health Rep. 2007, 122:472-481.
17. Goldie S.J., Paltiel A.D., Weinstein M.C., Losina E., Seage G.R., Kimmel A.D., Walensky R.P., Sax P.E., Freedberg K.A. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am. J. Med. 2003, 115:632-641.
18. Gourevitch M.N., Chatterji P., Deb N., Schoenbaum E.E., Turner B.J. On-site medical care in methadone maintenance: associations with health care use and expenditures. J. Subst. Abuse Treat. 2007, 32:143-151.
19. Khanlou H., Kandula V.R., Yeh V., Stein T.G., Sanchez S., Ricaurte J.C., Bhatti L., Farthing C.F. Pilot study of directly observed therapy in highly nonadherent HIV-infected patients in an urban community-based institution. J. Acquir. Immune. Defic. Syndr. 2003, 33:651-653.
20. Kirkland L.R., Fischl M.A., Tashima K.T., Paar D., Gensler T., Graham N.M., Gao H., Rosenzweig J.R., McClernon D.R., Pittman G., Hessenthaler S.M., Hernandez J.E. Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment. Clin. Infect. Dis. 2002, 34:511-518.
21. Lanzafame M., Trevenzoli M., Cattelan A.M., Rovere P., Parrinello A. Directly observed therapy in HIV therapy: A realistic perspective?. J. Acquir. Immune. Defic. Syndr. 2000, 25:200-201.
22. Litwin A.H., Harris K.A., Nahvi S., Zamor P.J., Soloway I.J., Tenore P.L., Kaswan D., Gourevitch M.N., Arnsten J.H. Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. J. Subst. Abuse Treat. 2009, 37:32-40.
23. Lucas G.M., Mullen B.A., McCaul M.E., Weidle P.J., Hader S., Moore R.D. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy. AIDS Patient Care STDS 2007, 21:564-574.
24. Lucas G.M., Mullen B.A., Weidle P.J., Hader S., McCaul M.E., Moore R.D. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clin. Infect. Dis. 2006, 42:1628-1635.
25. Lucas G.M., Weidle P.J., Hader S., Moore R.D. Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study. Clin. Infect. Dis. 2004, 38(Suppl 5):S409-S413.
26. Ma M., Brown B.R., Coleman M., Kibler J.L., Loewenthal H., Mitty J.A. The feasibility of modified directly observed therapy for HIV-seropositive African American substance users. AIDS Patient Care STDS 2008, 22:139-146.
27. Macalino G.E., Celentano D.D., Latkin C., Strathdee S.A., Vlahov D. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ. Prev. 2002, 14:367-378.
28. Macalino G.E., Hogan J.W., Mitty J.A., Bazerman L.B., Delong A.K., Loewenthal H., Caliendo A.M., Flanigan T.P. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS 2007, 21:1473-1477.
29. Malta M., Strathdee S.A., Magnanini M.M., Bastos F.I. Adherence to Antiretroviral Therapy for Human Immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction 2008, 103(8):1242-1257.
30. Mauss S., Berger F., Goelz J., Jacob B., Schmutz G. A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance. Hepatology 2004, 40:120-124.
31. Mitty J.A., Macalino G.E., Bazerman L.B., Loewenthal H.G., Hogan J.W., MacLeod C.J., Flanigan T.P. The use of community-based modified directly observed therapy for the treatment of HIV-infected persons. J. Acquir. Immune. Defic. Syndr. 2005, 39:545-550.
32. Mitty J.A., Stone V.E., Sands M., Macalino G., Flanigan T. Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress. Clin. Infect. Dis. 2002, 34:984-990.
33. Mizuno Y., Purcell D.W., Mackenzie S., Tobin K.E., Wunch T., Arnsten J.H., Metsch L.R. Acceptability of A-CASI by HIV-positive IDUs in a multisite, randomized, controlled trial of behavioral intervention (INSPIRE). J. Acquir. Immune. Defic. Syndr. 2007, 46(Suppl 2):S48-S54.
34. Pearson C.R., Micek M.A., Simoni J.M., Hoff P.D., Matediana E., Martin D.P., Gloyd S.S. Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. J. Acquir. Immune. Defic. Syndr. 2007, 46:238-244.
35. Simoni J.M., Kurth A.E., Pearson C.R., Pantalone D.W., Merrill J.O., Frick P.A. Self-Report Measures of Antiretroviral Therapy Adherence: A Review with Recommendations for HIV Research and Clinical Management. AIDS Behavior. 2006, 10:227-245.
36. Tang Y.H., Pang S.M., Chan M.F., Yeung G.S., Yeung V.T. Health literacy, complication awareness, and diabetic control in patients with type 2 diabetes mellitus. J. Adv. Nurs. 2008, 62:74-83.
37. Tinoco I., Giron-Gonzalez J.A., Gonzalez-Gonzalez M.T., Vergara de C.A., Rodriguez-Felix L., Serrano A., Bascunana A. Efficacy of directly observed treatment of HIV infection: experience in AIDS welfare homes. Eur. J. Clin. Microbiol. Infect. Dis. 2004, 23(4):331-335.
38. Weis S.E., Slocum P.C., Blais F.X., King B., Nunn M., Matney G.B., Gomez E., Foresman B.H. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N. Engl. J. Med. 1994, 330:1179-1184.
39. Wohl A.R., Garland W.H., Valencia R., Squires K., Witt M.D., Kovacs A., Larsen R., Hader S., Anthony M.N., Weidle P.J. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention. Clin. Infect. Dis. 2006, 42:1619-1627.